The accuracy and stability of Bayesian theophylline predictions

Area of Science:

• Pharmacokinetics
• Clinical Pharmacology
• Biostatistics

Background:

• Accurate theophylline dosing is crucial for therapeutic efficacy and minimizing toxicity.
• Traditional methods like one-compartmental models and nomograms have limitations in predicting serum concentrations.
• Bayesian analysis offers a potential improvement for individualized drug dosing.

Purpose of the Study:

• To compare the predictive accuracy of Bayesian analysis with standard one-compartmental models and drug nomograms for theophylline dosing.
• To evaluate the bias and precision of different pharmacokinetic parameter estimation methods.

Main Methods:

• Pharmacokinetic parameters for theophylline were determined in 33 patients using three methods: standard one-compartmental model, drug nomogram, and Bayesian analysis.
• Patients received randomized, two-monthly dosage regimens of low, medium, and high theophylline doses twice daily.
• Measured steady-state serum theophylline concentrations were compared with predicted values from each method.

Main Results:

• Bayesian analysis provided the least biased (lowest mean prediction error) and most precise (lowest mean squared prediction error) predictions across all dosage levels.
• The precision of Bayesian estimates significantly improved compared to other methods (p < 0.05), with improvement increasing with dose.
• Bayesian estimates were also significantly less biased than nomogram predictions (p < 0.05).

Conclusions:

• Revised estimates derived from Bayesian analysis demonstrate superior accuracy in predicting theophylline serum concentrations.
• Bayesian analysis is a valuable tool for optimizing theophylline dosing, offering improved precision and reduced bias.
• The benefits of Bayesian analysis become more pronounced at higher therapeutic doses of theophylline.